tirzepatide weight loss timeline Timeline: What Clinical Data Shows – PlexusDx Men before and after tirzepatide: – How much weight loss would

Tirzepatide has shown promising cardiovascular and heart failure benefits, including positive outcomes in people with obesity and heart failure with preserved ejection fraction

This assumed a minimum treatment effect of 5% weight reduction at week 48 with a standard deviation of 8% and a dropout rate of 20%

Its getting a lot of attention for its impressive weight-loss results, but the medication isnt even FDA approved yet

To fully assess this, future studies should explore additional time points post IOP increase in various glaucoma and RGC injury models as well as assess dosing parameters to increase efficacy (e.g